| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0002 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0002 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |